NCT01428518View on ClinicalTrials.gov

Special Drug Use Investigation for LAMICTAL Bipolar

CompletedOBSERVATIONAL

Enrollment

1,036

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Bipolar Disorder

Interventions

DRUG

Lamotrigine tablets

Administered according to the prescribing information in the locally approved label by the authorities.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01428518 - Special Drug Use Investigation for LAMICTAL Bipolar | Biotech Hunter | Biotech Hunter